Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 230

1.

DNA methylation markers and early recurrence in stage I lung cancer.

Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky SA, Yang SC, Baylin SB, Herman JG.

N Engl J Med. 2008 Mar 13;358(11):1118-28. doi: 10.1056/NEJMoa0706550.

PMID:
18337602
[PubMed - indexed for MEDLINE]
Free Article
2.

Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.

Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.

Lung Cancer. 2007 Oct;58(1):131-8. Epub 2007 Jul 2.

PMID:
17606310
[PubMed - indexed for MEDLINE]
3.

Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.

Kim JS, Kim JW, Han J, Shim YM, Park J, Kim DH.

Cancer Res. 2006 Apr 15;66(8):4049-54.

PMID:
16618724
[PubMed - indexed for MEDLINE]
Free Article
4.

Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.

Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH.

J Clin Oncol. 2004 Jun 15;22(12):2363-70.

PMID:
15197197
[PubMed - indexed for MEDLINE]
Free Article
5.

PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.

Buckingham L, Penfield Faber L, Kim A, Liptay M, Barger C, Basu S, Fidler M, Walters K, Bonomi P, Coon J.

Int J Cancer. 2010 Apr 1;126(7):1630-9. doi: 10.1002/ijc.24896.

PMID:
19795445
[PubMed - indexed for MEDLINE]
6.

Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.

Toyooka S, Maruyama R, Toyooka KO, McLerran D, Feng Z, Fukuyama Y, Virmani AK, Zochbauer-Muller S, Tsukuda K, Sugio K, Shimizu N, Shimizu K, Lee H, Chen CY, Fong KM, Gilcrease M, Roth JA, Minna JD, Gazdar AF.

Int J Cancer. 2003 Jan 10;103(2):153-60.

PMID:
12455028
[PubMed - indexed for MEDLINE]
7.

Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.

Kim JS, Han J, Shim YM, Park J, Kim DH.

Cancer. 2005 Nov 1;104(9):1825-33. Review.

PMID:
16177988
[PubMed - indexed for MEDLINE]
Free Article
8.

Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.

Saito K, Kawakami K, Matsumoto I, Oda M, Watanabe G, Minamoto T.

Clin Cancer Res. 2010 Apr 15;16(8):2418-26. doi: 10.1158/1078-0432.CCR-09-2819. Epub 2010 Apr 6.

PMID:
20371677
[PubMed - indexed for MEDLINE]
Free Article
9.

Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.

Wang Y, Zhang D, Zheng W, Luo J, Bai Y, Lu Z.

Cancer. 2008 Mar 15;112(6):1325-36. doi: 10.1002/cncr.23312.

PMID:
18286531
[PubMed - indexed for MEDLINE]
Free Article
10.

Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.

Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, Wang YC.

Cancer. 2007 Nov 1;110(9):2019-26.

PMID:
17876837
[PubMed - indexed for MEDLINE]
Free Article
11.

Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.

Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, Singer J, Sidransky D, Hölscher AH, Meltzer SJ, Danenberg PV.

Oncogene. 2001 Jun 14;20(27):3528-32.

PMID:
11429699
[PubMed - indexed for MEDLINE]
Free Article
12.

RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer.

Choi N, Son DS, Song I, Lee HS, Lim YS, Song MS, Lim DS, Lee J, Kim H, Kim J.

Int J Cancer. 2005 Jul 1;115(4):575-81.

PMID:
15700308
[PubMed - indexed for MEDLINE]
13.

Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma.

Maruyama R, Sugio K, Yoshino I, Maehara Y, Gazdar AF.

Cancer. 2004 Apr 1;100(7):1472-7.

PMID:
15042681
[PubMed - indexed for MEDLINE]
Free Article
14.

Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?

Kim YT, Lee SH, Sung SW, Kim JH.

Ann Thorac Surg. 2005 Apr;79(4):1180-8; discussion 1180-8.

PMID:
15797047
[PubMed - indexed for MEDLINE]
15.

The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.

Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, Morita M, Yasumoto K.

Cancer. 2006 May 15;106(10):2190-9.

PMID:
16598757
[PubMed - indexed for MEDLINE]
Free Article
16.

Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer.

Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, Mark EJ, Kelsey KT.

Oncogene. 2001 Mar 29;20(14):1765-70.

PMID:
11313923
[PubMed - indexed for MEDLINE]
Free Article
17.

Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers.

Yoshino M, Suzuki M, Tian L, Moriya Y, Hoshino H, Okamoto T, Yoshida S, Shibuya K, Yoshino I.

Int J Oncol. 2009 Nov;35(5):1201-9.

PMID:
19787276
[PubMed - indexed for MEDLINE]
18.

DNA methylation profiles of lung tumors.

Toyooka S, Toyooka KO, Maruyama R, Virmani AK, Girard L, Miyajima K, Harada K, Ariyoshi Y, Takahashi T, Sugio K, Brambilla E, Gilcrease M, Minna JD, Gazdar AF.

Mol Cancer Ther. 2001 Nov;1(1):61-7.

PMID:
12467239
[PubMed - indexed for MEDLINE]
Free Article
19.

Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.

Liu Y, Gao W, Siegfried JM, Weissfeld JL, Luketich JD, Keohavong P.

BMC Cancer. 2007 May 3;7:74.

PMID:
17477876
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.

Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT.

Cancer Res. 2001 Apr 15;61(8):3419-24.

PMID:
11309302
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk